From July 1, 2022 to September 30, 2022, the company has repurchased 274,780 shares, representing 1.32% for CAD 0.18 million. With this, the company has completed the repurchase of 556,010 shares, representing 2.67% for CAD 0.99 million under the buyback announced on December 15, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.435 CAD | 0.00% | +1.16% | -11.22% |
08/05 | Crescita Therapeutics Q1 Loss Widens, Revenue Rises | MT |
08/05 | Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million | MT |
1st Jan change | Capi. | |
---|---|---|
-11.22% | 6.2M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- CTX Stock
- News Crescita Therapeutics Inc.
- Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on December 15, 2021.